Fusion IV Pharmaceuticals (Axia Pharmaceutical) is voluntarily recalling numerous lots of various sterile injectable drug products, including Alprostadil, Betamethasone, Cyanocobalamin, and Testosterone, because they may not be sterile. The lack of sterility assurance was discovered following an FDA inspection of the manufacturing facility. While no injuries or infections have been reported to date, using a non-sterile injectable medication can lead to serious, life-threatening infections. These prescription-only medications were distributed nationwide across the U.S. and to several international locations.
Injecting a product that lacks sterility assurance can introduce bacteria or fungi directly into the body, potentially causing severe systemic infections or abscesses. This risk is especially high for patients with weakened immune systems who may be unable to fight off such infections.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.